Thursday, Nov 14, 2019
Health & Medicine Legalization News

FDA approves first-ever marijuana-based drug in US to help treat epilepsy

Medical marijuana is legal in roughly half of all US states ( Getty Images )

The US Food and Drug Administration (FDA) has given its first ever approval for a drug derived from marijuana.

The drug, Epidiolex, is intended to help treat seizures stemming from two rare but severe forms of epilepsy that first take hold during childhood.

The drug is produced by GW Pharmaceuticals, a British biotech company that is perhaps best known for the cannabis-based multiple sclerosis drug Sativex. That drug has been approved for use in as many as 30 countries outside of the United States.

The first-of-its-kind approval in the US could lead to more research and development of marijuana-based drugs going forward.

“This approval serves as a reminder that advancing sound development programmes that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” Scott Gottlieb, the commissioner of the FDA, said in a statement.

While medical marijuana has been legalized for medical purposes in nearly half of the states in the US — and a handful of states have legalized recreational use — the drug is still a Schedule 1 drug under federal law.

To Read The Rest Of This Article By Clark Mindock on Independent

Click Here

Published: June 25, 2018

Canopy’s $350M Hiku Acquisition Underscores the Value of Cannabis Brands
FLOURISH™ Announces Retention Bonus & January’s “Golden Jay Award” Winner
MERRY JANE Co-Founder Launches Cannabis Agency ‘Gram By Gram’

Leave Your Reply


Translate »